Total body irradiation dose and relapse risk after marrow transplantation for leukemia
- PMID: 2039837
Total body irradiation dose and relapse risk after marrow transplantation for leukemia
Comment on
-
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.Blood. 1990 Nov 1;76(9):1867-71. Blood. 1990. PMID: 2224134 Clinical Trial.
Similar articles
-
Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.Bone Marrow Transplant. 1993;11 Suppl 1:83. Bone Marrow Transplant. 1993. PMID: 8448558 No abstract available.
-
Effects of treatment regimens on post marrow transplant relapse.Semin Hematol. 1991 Jul;28(3 Suppl 4):32-4. Semin Hematol. 1991. PMID: 1780749 Review. No abstract available.
-
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.Bone Marrow Transplant. 1991;7 Suppl 2:130. Bone Marrow Transplant. 1991. PMID: 1878675 Clinical Trial. No abstract available.
-
Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse.Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):547-52. doi: 10.1016/0360-3016(89)90105-3. Int J Radiat Oncol Biol Phys. 1989. PMID: 2674077
-
[Total body irradiation in hematology: clinical indications and prospects].Recenti Prog Med. 1999 Nov;90(11):601-4. Recenti Prog Med. 1999. PMID: 10608150 Review. Italian. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical